Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Both drugs affect your gastrointestinal system, making proper timing and food intake critical for tolerability and effectiveness
A phase 2 study of prostate specific membrane antigen antibody drug conjugate (PSMA ADC) in patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following abiraterone and/or enzalutamide (abi/enz)
Dang AT, Marsland BJ (2019) Microbes, metabolites, and the gut-lung axis
About the study The phase 3a, multicenter, randomized, double-blind, placebo- and active-controlled REDEFINE 1 trial enrolled 3,417 adults across 22 countries
US$ 27.05
US$ 29.33
US$ 24.97
